Huang Fei, Ma Yu-Cong, Wang Fang, Li Ya-Nan
Department of Orthopedics, China Japan Union Hospital of Jilin University, Changchun, Jilin, PR China.
Department of Pediatrics, The First Hospital of Jilin University, Changchun, Jilin, PR China.
Lung India. 2021 Mar-Apr;38(2):117-121. doi: 10.4103/lungindia.lungindia_374_20.
Postinfectious bronchiolitis obliterans (PIBO) is an uncommon and severe form of chronic obstructive lung disease in children. Adenovirus (ADV) is the main pathogen of PIBO in children. However, the risk factors of ADV-PIBO are not fully understood. This study aims to analyze the clinical characteristics of PIBO caused by ADV and compared with non-ADV-PIBO.
A retrospective study of children under the age of 14 years diagnosed PIBO was performed in 56 ADV-PIBO cases, 29 non-ADV-PIBO, and 39 healthy controls to determine clinical characteristics of PIBO.
There was no difference between ADV-PIBO and non-ADV-PIBO cases in gender, age, individual and family atopy or history of asthma, and previous history of wheezing and no difference in the clinical manifestations and signs between the two groups. However, the hospital stay, duration of ventilator use, and multifocal pneumonia incidence of ADV-PIBO group have a significant differences compared with non-ADV-PIBO. Notably, inflammatory markers lactic dehydrogenase (LDH), interleukin 8 (IL-8), and interferon-gamma (IFN-γ) were significantly increased in PIBO patients, and those expressed in ADV-PIBO patients were higher than those in non-ADV-PIBO patients. In addition, ADV-PIBO children required a longer duration of oral prednisone and azithromycin than non-ADV-PIBO cases.
Compared with non-ADV-PIBO, ADV-PIBO has a longer hospital stay, longer duration of ventilator use, increased LDH, IL-8, and IFN-γ expressions, and longer duration of oral prednisone and azithromycin treatment. Further research is needed to determine why PIBO caused by ADVs are more severe than those caused by other pathogens.
感染后闭塞性细支气管炎(PIBO)是儿童慢性阻塞性肺疾病的一种罕见且严重的形式。腺病毒(ADV)是儿童PIBO的主要病原体。然而,ADV - PIBO的危险因素尚未完全明确。本研究旨在分析ADV引起的PIBO的临床特征,并与非ADV - PIBO进行比较。
对56例ADV - PIBO患儿、29例非ADV - PIBO患儿及39例健康对照进行回顾性研究,这些患儿年龄均在14岁以下,以确定PIBO的临床特征。
ADV - PIBO组与非ADV - PIBO组在性别、年龄、个体及家族过敏体质或哮喘病史、既往喘息史方面无差异,两组临床表现及体征也无差异。然而,ADV - PIBO组的住院时间、呼吸机使用时间及多灶性肺炎发生率与非ADV - PIBO组相比有显著差异。值得注意的是,PIBO患者炎症标志物乳酸脱氢酶(LDH)、白细胞介素8(IL - 8)和干扰素 - γ(IFN - γ)显著升高,且ADV - PIBO患者的这些指标高于非ADV - PIBO患者。此外,ADV - PIBO患儿口服泼尼松和阿奇霉素的时间比非ADV - PIBO患儿长。
与非ADV - PIBO相比,ADV - PIBO住院时间更长、呼吸机使用时间更长、LDH、IL - 8和IFN - γ表达增加,口服泼尼松和阿奇霉素治疗时间更长。需要进一步研究以确定为何ADV引起的PIBO比其他病原体引起的更严重。